SCYNEXIS, Inc. to Present at Upcoming Investor Conferences

JERSEY CITY, N.J., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Drug development company SCYNEXIS, Inc. (NASDAQ:SCYX) today announced that the Company will present at the following upcoming investor conferences in February:

  • Leerink Partners 5th Annual Global Healthcare Conference at the Waldorf Astoria Hotel in New York City on Thursday, February 11, 2016 at 8:55 a.m. ET; and
  • RBC Capital Markets 2016 Healthcare Conference at the New York Palace Hotel in New York City on Wednesday, February 24, 2016 at 11:30 a.m. ET.

A live webcast of each presentation will be available on the investors section of the Company's website: A replay of each presentation will be available approximately two hours after each event and will be available for two weeks following the presentation.

SCYNEXIS, Inc. is a pharmaceutical company committed to the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. We are developing our lead product candidate, SCY-078, as an oral and IV drug for the treatment of serious and life-threatening invasive fungal infections in humans. For more information, visit



Media Relations
Heather Savelle
MacDougall Biomedical Communications
Tel: 781.235.3060

Investor Relations
Susan Kim
Argot Partners
Tel: 212-203-4433

Primary Logo

Source: SCYNEXIS, Inc.